Search Results - Muhammad Tukur Ibrahim
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions by Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Paul Andrew Mamza, Muhammad Tukur Ibrahim
Published in Heliyon (2022-08-01)Get full text
Article -
4
In silico screening, pharmacokinetic, DFT, and dynamics simulation study of ant-hepatitis C virus compounds as potential NS5B Polymerase inhibitors by Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, Stephen Eyije Abechi, Muhammad Tukur Ibrahim
Published in Scientific African (2024-03-01)Get full text
Article -
5
Retraction notice to “In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET pr... by Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Paul Andrew Mamza, Muhammad Tukur Ibrahim
Published in Heliyon (2023-08-01)Get full text
Article -
6
Computer-aided molecular modeling and design studies of some N-(4-(dimethyl amino) phenyl)-4-methoxy-3-propionamidobenzamide derivatives as NS5B polymerase inhibitors by Abubakar Sadiq Bello, A. Uzairu, G.A. Shallangwa, A. Ibrahim, Muhammad Tukur Ibrahim
Published in The Microbe (2024-09-01)Get full text
Article -
7
-
8
Modelling of novel bornoel analogs as Influenza A Virus inhibitors through genetic function approximation, comparative molecular fields, molecular docking, and ADMET/Pharmacokineti... by Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Paul Andrew Mamza, Muhammad Tukur Ibrahim
Published in Intelligent Pharmacy (2024-04-01)Get full text
Article -
9
Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predic... by Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Paul Andrew Mamza, Muhammad Tukur Ibrahim
Published in Beni-Suef University Journal of Basic and Applied Sciences (2022-08-01)Get full text
Article -
10
Design of some potent non-toxic Autoimmune disorder inhibitors based on 2D-QSAR, CoMFA, molecular docking, and molecular dynamics investigations by Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa, Muhammad Tukur Ibrahim
Published in Intelligent Pharmacy (2024-10-01)Get full text
Article -
11
Evaluation of novel Anti-SARS-CoV-2 compounds by targeting nucleoprotein and envelope protein through homology modeling, docking simulations, ADMET, and molecular dynamic simulatio... by Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa, Muhammad Tukur Ibrahim
Published in Intelligent Pharmacy (2024-06-01)Get full text
Article -
12
Towards designing of some potential new autoimmune disorder inhibitors using crystal structures and Hirshfeld surface analyses in combination with molecular docking and molecular d... by Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa, Muhammad Tukur Ibrahim
Published in Intelligent Pharmacy (2024-04-01)Get full text
Article -
13
Potential anti-colon cancer agents: Molecular modelling, docking, pharmacokinetics studies and molecular dynamic simulations by Auwal Salisu Isa, Adamu Uzairu, Umar Mele Umar, Muhammad Tukur Ibrahim, Abdullahi Bello Umar, Iqrar Ahmad
Published in Journal of Holistic Integrative Pharmacy (2024-09-01)Get full text
Article -
14
-
15
In-silico design of novel 2-((4-chloro-6-methoxy-1H-indol-3-yl)thio)-N-(2-ethoxyphenyl)acetamide derivatives as potential inhibitors of influenza neuraminidase protein receptor by Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Paul Andrew Mamza, Muhammad Tukur Ibrahim, Anshuman Chandra, Nagendra Singh
Published in Intelligent Pharmacy (2024-08-01)Get full text
Article -
16
Halogenated 2,4-diphenyl indeno[1,2-B]pyridinol derivatives as potential inhibitors of the androgen receptor (PDB ID: 58TE): A study of QSAR modeling, molecular docking, and pharma... by Auwal Salisu Isa, Adamu Uzairu, Umar Mele Umar, Muhammad Tukur Ibrahim, David Ebuka Arthur, Samuel Ndaghiya Adawara
Published in Biomedical Analysis (2024-09-01)Get full text
Article -
17
Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis... by Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, Stephen Eyije Abechi, Muhammad Tukur Ibrahim, Ramith Ramu, Mohammed Al-Ghorbani
Published in Scientific African (2023-07-01)Get full text
Article -
18
In silico exploration of novel EGFR-targeting compounds: integrative molecular modeling, docking, pharmacokinetics, and MD simulations for advancing anti-cervical cancer therapeuti... by Auwal Salisu Isa, Adamu Uzairu, Umar Meleh Umar, Muhammad Tukur Ibrahim, Abdullahi Bello Umar, Kamal Tabti, Abdussamad Mukhtar Mohammed
Published in Scientific Reports (2025-03-01)Get full text
Article -
19
In-silico exploration and structure-based design of Praziquantel derivatives as potential inhibitors of schistosoma mansoni Glutathione S-transferase (SmGST) by Saudatu Chinade Jáafaru, Adamu Uzairu, Muhammed Sani Sallau, George Iloegbulam Ndukwe, Muhammad Tukur Ibrahim, Kamal Tabti, Pallavi Kandpal, Vimal Kumar
Published in Scientific African (2024-06-01)Get full text
Article -
20
Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies by Sagiru Hamza Abdullahi, Abu Tayab Moin, Adamu Uzairu, Abdullahi Bello Umar, Muhammad Tukur Ibrahim, Mustapha Tijjani Usman, Nafisa Nawal, Imren Bayil, Talha Zubair
Published in Intelligent Pharmacy (2024-04-01)Get full text
Article